Final answer:
The drug that requires the patient to be enrolled in a risk management course is Alosetron (Lotronex). This drug is used to treat women with severe chronic irritable bowel syndrome (IBS) who have not responded to other treatments.
Step-by-step explanation:
The drug that requires the patient to be enrolled in a risk management course is A) Alosetron (Lotronex). This drug is used to treat women with severe chronic irritable bowel syndrome (IBS) who have not responded to other treatments. Due to the risk of severe side effects, including ischemic colitis and severe constipation, the FDA requires patients and prescribers to be enrolled in a risk management program.
During the course, patients receive information about the potential risks and benefits of Alosetron, and they are educated on how to recognize and manage potential side effects and complications. This risk management program aims to ensure that the benefits of the drug are weighed against the potential risks and that patients are well-informed to make decisions about their treatment.